126 related articles for article (PubMed ID: 29562499)
21. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
22. Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates.
Mahasneh A; Al-Shaheri F; Jamal E
Exp Mol Pathol; 2017 Jun; 102(3):475-483. PubMed ID: 28506769
[TBL] [Abstract][Full Text] [Related]
23. High frequency of KRAS mutation in early onset colorectal adenocarcinoma: implications for pathogenesis.
Watson R; Liu TC; Ruzinova MB
Hum Pathol; 2016 Oct; 56():163-70. PubMed ID: 27346571
[TBL] [Abstract][Full Text] [Related]
24. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
[TBL] [Abstract][Full Text] [Related]
25. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
[TBL] [Abstract][Full Text] [Related]
26. Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma.
Conesa-Zamora P; García-Solano J; García-García F; Turpin Mdel C; Trujillo-Santos J; Torres-Moreno D; Oviedo-Ramírez I; Carbonell-Muñoz R; Muñoz-Delgado E; Rodriguez-Braun E; Conesa A; Pérez-Guillermo M
Int J Cancer; 2013 Jan; 132(2):297-307. PubMed ID: 22696308
[TBL] [Abstract][Full Text] [Related]
27. Statistical analysis of differential gene expression in colorectal cancer using CLEAR-test.
Mazurek U; Owczarek A; Nowakowska-Zajdel E; Wierzgon J; Grochowska-Niedworok E; Kokot T; Muc-Wierzgon M
J Biol Regul Homeost Agents; 2011; 25(2):279-83. PubMed ID: 21880217
[TBL] [Abstract][Full Text] [Related]
28. The Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Colorectal Cancer.
Ozemir IA; Aslan S; Eren T; Bayraktar B; Bilgic C; Isbilen B; Yalman H; Yigitbasi R; Alimoglu O;
Chirurgia (Bucur); 2016; 111(5):414-421. PubMed ID: 27819647
[TBL] [Abstract][Full Text] [Related]
29. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum.
Varghese S; Burness M; Xu H; Beresnev T; Pingpank J; Alexander HR
Ann Surg Oncol; 2007 Dec; 14(12):3460-71. PubMed ID: 17899288
[TBL] [Abstract][Full Text] [Related]
30. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
31. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
[TBL] [Abstract][Full Text] [Related]
32. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
33. Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer.
Ciarloni L; Ehrensberger SH; Imaizumi N; Monnier-Benoit S; Nichita C; Myung SJ; Kim JS; Song SY; Kim TI; van der Weg B; Meier R; Borovicka J; Beglinger C; Vallet C; Maerten P; Rüegg C; Dorta G
Clin Cancer Res; 2016 Sep; 22(18):4604-11. PubMed ID: 27126992
[TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma.
Kim CY; Jung WY; Lee HJ; Kim HK; Kim A; Shin BK
Oncol Rep; 2012 Mar; 27(3):608-20. PubMed ID: 22076435
[TBL] [Abstract][Full Text] [Related]
35. Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma.
Xu X; Feng L; Liu Y; Zhou WX; Ma YC; Fei GJ; An N; Li Y; Wu X; Yao F; Cheng SJ; Lu XH
World J Gastroenterol; 2014 Dec; 20(47):17883-93. PubMed ID: 25548486
[TBL] [Abstract][Full Text] [Related]
36. Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection.
Rodia MT; Ugolini G; Mattei G; Montroni I; Zattoni D; Ghignone F; Veronese G; Marisi G; Lauriola M; Strippoli P; Solmi R
Oncotarget; 2016 May; 7(21):30295-306. PubMed ID: 26993598
[TBL] [Abstract][Full Text] [Related]
37. Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer.
Hamm A; Prenen H; Van Delm W; Di Matteo M; Wenes M; Delamarre E; Schmidt T; Weitz J; Sarmiento R; Dezi A; Gasparini G; Rothé F; Schmitz R; D'Hoore A; Iserentant H; Hendlisz A; Mazzone M
Gut; 2016 Jun; 65(6):990-1000. PubMed ID: 25814648
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target.
Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H
Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125
[TBL] [Abstract][Full Text] [Related]
39. [Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma].
Xu C; Liu YL; Huang J; He DM; Hou YY; Ji Y; Hou J; Lu SH; Xu JF; Hu Q; Shi Y; Zhao LJ; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):667-70. PubMed ID: 23302307
[TBL] [Abstract][Full Text] [Related]
40. Expression Profile of Genes Associated with the Proteins Degradation Pathways in Colorectal adenocarcinoma.
Martyna B; Małgorzata MW; Nikola Z; Beniamin G; Urszula M; Grażyna J
Curr Pharm Biotechnol; 2019; 20(7):551-561. PubMed ID: 31096896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
